- Roche offers $75 cash/share for histopathology player Ventana
- GSK signs second MAGE-A3 collaboration with Abbott Molecular
- Abbott, GSK to develop diagnostic for NSCLC
- Abbott to develop companion Dx for Pfizer's NSCLC candidate
- Merck gets access to Roche's AmpliChip p53 test
- Merck and Schering-Plough to merge in $42bn deal
- LabCorp buys Monogram Biosciences for $107mm plus debt
- Monogram Biosciences, Pfizer collaborate on HIV assay
- Novartis Molecular Diagnostics signs deal with Orion Genomics
- Novartis gets an option to Transgene's TG4010; option not exercised
- Chiron refuses $4.5bn Novartis offer, later accepts $5.1bn
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.